Award
National Heart, Lung, and Blood Institute 1R41HL177991-01
Approaches to enable large scale heparin bio-manufacturing
Recipient
Not specified
Award Amount
$306,656.00
Ceiling
$306,656.00
Awarded
January 20, 2025
Identifier
1R41HL177991-01
Award for research and development of large scale heparin bio-manufacturing using engineered microbial factories as a modern alternative to animal-derived heparin, funded by NHLBI, NIH.
Description
The project involves biotechnological approaches to produce heparin using engineered microbial factories. The project aims to provide a reliable, modern alternative to animal-derived heparin. It emphasizes the importance of supply chain security for heparin.